Lobachevsky University researchers study the effects of bee venom on living organisms

December 19, 2017

Despite a centuries-old history of studies of bee venom as a therapeutic agent, this field of research remains quite relevant today, when the use of synthetic drugs is not always effective and has a great number of side effects. In addition to analgesic properties of bee venom that are well known, a number of other useful properties have been established experimentally such as the ability to reduce blood pressure, antiarrhythmic action, radioprotective and antihypoxic effects, as well as antitumor activity.

Bee venom's high polyfunctionality is based on a unique combination of its components, including some proteins with enzymatic properties, highly active peptides (melittin, apamin, the mast-cell-degranulating (MCD) peptide, adolapin, tertiapin, secapin, minimin, cardiopep), and biogenic amines.

Bee venom peptides have an anti-inflammatory effect, both through direct action and indirectly through the modulation of all other regulatory systems. Thus, the pharmacological activity of small doses of melittin is mediated by the activation of a cascade associated with the synthesis of prostaglandins, which are powerful biological regulators. In addition, melittin has some protective properties, which underlies the radioprotective effects of bee venom. Melittin is also credited with antitumor activity. Its anti-inflammatory activity is associated with the action of the MCD-peptide, while adolapin, a component of bee venom, has an analgesic effect.

As they enter the body, bee venom components cause changes in the neurohumoral regulation of body functions not only through the activation of endogenous neuropeptides, but, possibly, as their direct sources.

Researchers of the UNN Institute of Biology and Biomedicine (IBBM) have established as a result of laboratory tests that bee venom and bee products inhibit the growth of malignant tumors, enhance biological activity of the body, and can also be used to treat diabetes mellitus.

Anna Deryugina, Head of the Department of Physiology and Anatomy of the UNN IBBM explains: "Currently, we are continuing the tests of a chemical compound including chitosan, gold nanoparticles and bee venom, in particular, in relation to the treatment of oncological diseases. We have found out that the compound synthesized by our colleagues at the UNN Faculty of Chemistry inhibits the growth of malignant tumors. Our institute has been testing this compound on rats for several years. This process takes quite a while, as always in medical tests. We look forward to the day in the future when cancer patients will be treated with beekeeping products, but athletes can already use these substances to enhance their performance and set records."

"This is a permitted biostimulator, which increases physical potential", continues Anna Deryugina. - "In particular, we are talking about royal jelly and propolis. We have also proved that bee venom can be used in the treatment of diabetes mellitus. Strange as it may seem, bee venom lowers the amount of sugar in the blood. Royal jelly and honey also reduce the sugar level. These drugs can be used for type 2 diabetes mellitus. They can also be used for type 1 diabetes, but with a much weaker effect. Of course, it is best to use royal jelly and honey for prevention, when the blood sugar level has not crossed the critical line."

UNN researchers are working to determine an effective dose of bee products. However, there are no doubts that bee venom and bee products can be used as biologically active additives to correct certain states of the human body.

"Our tests are especially important for the treatment of oncological diseases and diabetes mellitus, because they share the second place among the causes of death and are second only to cardiovascular diseases," - concludes the expert.

It is important to note that the therapeutic effect of bee venom is determined by the dose of poison administered. Upon exposure to bee venom, a stress reaction develops, which results in the activation of stress-realizing systems of the body. Thus, the protective forces and adaptive reserves of the body are enhanced, which can be effectively used in clinical medicine.
-end-


Lobachevsky University

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.